Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease

Abroad (travel likely)Recruiting

Conditions

Thyroid Eye Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Dept. of Nuclear Medicine, Peking University Third Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Hui Li, Dr.) · huilee1990@163.com · 86-13121136769
Contact: Study coordinator (Lingge Suo, Dr.) · suolingge_1019@126.com · 86-010-82264935
Contact: Principal Investigator (Hui Li, Dr.)

Study leads

Hui Li, Dr.
Principal Investigator
Peking University Third Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of IBI3031 in Participants With Thyroid Eye Disease

Thyroid Eye Disease

Abroad (travel likely)RecruitingPHASE1

Shenyang, China

A Clinical Study of Cizutamig in Thyroid Eye Disease

Thyroid Eye Disease, TED

Abroad (travel likely)RecruitingPHASE1

Shanghai, China

Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease

Thyroid Eye Disease, TED · Graves Ophthalmopathy

Abroad (travel likely)Recruiting

Taipei, Taiwan

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease

Thyroid Eye Disease (TED)

Abroad (travel likely)RecruitingPHASE3

Shanghai, China